Posted on 10/27/16
Dr. Reddy's Laboratories Announces New Strategic Deal with Gland Pharma in the U.S. Market
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that it has entered into a strategic collaboration with . . .
Posted on 10/27/16
Virtua Partners with DocASAP
Virtua, one of New Jersey's largest health systems, has partnered with DocASAP to provide patients of its primary care physician practices and urgent care with advanced . . .
Posted on 10/27/16
Crunch Franchise Announces Its Newest Location In Columbia, SC
Crunch, the health club chain best known for making serious fitness fun through unique programming and cutting-edge training, announces the opening of its newest franchise location . . .
Posted on 10/27/16
Cigna, Cigna Foundation and Cordani Foundation Partner
BLOOMFIELD, Conn.--(BUSINESS WIRE)--Cigna (NYSE: CI) is revving up its community health and wellness efforts and announced today it will sponsor a cross-country Go. Know. Take Control. . . .
Posted on 10/27/16
Merck Prices EUR 1.0 Billion Debt Offering
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck & Co., Inc., (NYSE:MRK), known as MSD outside the United States and Canada, priced today a EUR 1.0 billion public offering of two . . .
Posted on 10/27/16
X-Rx and Mercachem Provide Update on Two Discovery-Stage Oncology Programs
NEW YORK & NIJMEGEN, The Netherlands--(BUSINESS WIRE)--X-Rx, Inc, a biotechnology company focused on the creation of small molecule drug candidates, and Mercachem BV, a leading chemistry . . .
Posted on 10/26/16
Tonix Pharmaceuticals Prices $5.2 Million Underwritten Public Offering
NEW YORK, Oct. 26, 2016 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp.(NASDAQ:TNXP) (Tonix), today announced the pricing of an underwritten public offering of 9,500,000 units, consisting . . .
Posted on 10/26/16
4 Top Drug Stocks That Can Be Purchased on the Cheap This Fall
SOME GREAT DRUG STOCKS COULD BE HIDING IN PLAIN VIEW. IMAGE SOURCE: GETTY IMAGES.U.S. stocks have been taken for a wild ride in 2016, but at . . .
Posted on 10/26/16
Better Buy: Celldex Therapeutics, Inc. vs. bluebird bio, Inc.
IMAGE SOURCE: GETTY IMAGES.Pipeline vs. pipeline.That's the match-up investors must consider when deciding which clinical-stage biotech stock to buy. Two such biotech stocks attracting plenty of . . .
Posted on 10/26/16
Blink Fitness To Open Its Newest Manhattan Location In East Village
Blink Fitness, the premium-quality, value-based fitness club, is excited to announce the opening of its newest Manhattan location in the East Village. The club will open . . .
Posted on 10/25/16
SCYNEXIS Completes Two Additional Clinical Studies
JERSEY CITY, N.J., Oct. 25, 2016 (GLOBE NEWSWIRE) -- Drug development company SCYNEXIS, Inc. (Nasdaq:SCYX) today announced the completion of two additional Drug-Drug Interaction (DDI) studies, . . .
Posted on 10/25/16
Braeburn Pharmaceuticals and Camurus Expand Collaboration and License Agreement
Braeburn Pharmaceuticals and Camurus (NASDAQ STO: CAMX) today announced the expansion of their collaboration and license agreement from 2014 to include buprenorphine combination products. The first . . .
Posted on 10/21/16
Quest Diagnostics Reports Third Quarter 2016 Financial Results
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that for the third quarter endedSeptember 30, 2016, reported net income . . .
Posted on 10/21/16
Hartford HealthCare Headache Center Awarded First Ever IMPACT Grant from Migraine Research Foundation
Dr. Brian Grosberg, medical director of the Hartford HealthCare Headache Program, was awarded the inaugural Migraine Research Foundation "Impact" Award, a$250,000 grant that will fund leading-edge . . .
Posted on 10/20/16
3 Reasons Bristol-Myers Is a Buy
IMAGE SOURCE: BRISTOL-MYERS SQUIBB.Fresh off a data release announcement providing full details of Opdivo's failure in its Phase 3 CheckMate-026 study, Bristol-Myers Squibb (NYSE:BMY) shares dipped . . .
Posted on 10/20/16
22nd Century Group Closes $11.4 Million Above-Market Registered Direct Offering
CLARENCE, N.Y.--(BUSINESS WIRE)--22nd Century Group, Inc. (NYSE MKT:XXII), a plant biotechnology company that is a leader in tobacco harm reduction, announced that the Company closed today . . .
Posted on 10/19/16
7 Reasons Celgene Is the Best Bet in Biotech
IMAGE SOURCE: GETTY IMAGES.Would you buy a house without inspecting its foundation? No way. And for exactly the same reason, don't ever buy a biotech stock . . .
Posted on 10/19/16
Better Buy: NantKwest, Inc. vs. Celldex Therapeutics, Inc.
IMAGE SOURCE: GETTY IMAGES.A match-up between NantKwest, Inc. (NASDAQ:NK) and Celldex Therapeutics, Inc.(NASDAQ:CLDX) might qualify for a biotech version of the TV show The Biggest Loser. . . .
Posted on 10/19/16
This Therapist is Set on Bringing Mental Health to Brooklyn’s Public Schools
It shouldn’t be that mental health is found only in the richest neighborhoods in a city, and yet, that is how it has seemed to
Posted on 10/19/16
Lung Cancer Research Foundation Announces 2016 Scientific Grant Program Awards
The Lung Cancer Research Foundation (LCRF™) announced the awardees of its 2016 Scientific Grant Program at the Eleventh Annual Lung Cancer Awareness Luncheon, held on Monday, . . .
Posted on 10/19/16
UnitedHealth Group Reports Third Quarter Results
NEW YORK--(BUSINESS WIRE)--UnitedHealth Group (NYSE:UNH) reported third quarter results reflecting well-balanced growth and steady execution across its diverse businesses.“Our growth indicators are positive as we conclude . . .
Posted on 10/19/16
Celgene Corp. and Sage Bionetworks Announce Technology Collaboration
SUMMIT, N.J. & SEATTLE--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) and Sage Bionetworks today announced a collaboration to develop an iPhone application utilizing the Apple ResearchKit framework to . . .
Posted on 10/18/16
Pfizer and Bristol-Myers Squibb Could Face a Big Threat from Small Biotech Exelixis
IMAGE SOURCE: GETTY IMAGES.Only 12% of patients with advanced kidney cancer survive five years or more. Exelixis(NASDAQ:EXEL) hopes to increase that number, and based on its . . .
Posted on 10/18/16
3 Reasons Pfizer Is A Screaming Buy Right Now
Pfizer (NYSE:PFE) hasn't had a good year, having both underperformed rivals such as Johnson & Johnson (NYSE:JNJ), and Merck (NYSE:MRK), as well as the S&P 500.PFE . . .
Posted on 10/18/16
Better Buy: Ionis Pharmaceuticals, Inc. vs. Celgene
IMAGE SOURCE: GETTY IMAGES.Both Ionis Pharmaceuticals (NASDAQ:IONS) and Celgene (NASDAQ:CELG) have seen better days. While both stocks soared over the past several years, 2016 hasn't been . . .
New York
